Shire plc - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information.
The report covers the company’s structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360˚ view of the company.
Detailed information on Shire plc required for business and competitor intelligence needs
A study of the major internal and external factors affecting Shire plc in the form of a SWOT analysis
An in-depth view of the business model of Shire plc including a breakdown and examination of key business segments
Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios for Shire plc
Intelligence on Shire plcnv’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about Shire plc, such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Shire (or ‘the company’) is a global specialty biopharmaceutical company. The company operates in North America, Europe and other countries. It is headquartered in Dublin, Republic of Ireland and employed 5,251 people as on December 31, 2011. The company recorded revenues of $4,263.4 million during the financial year ended December 2011 (FY2011), an increase of 22.8% over FY2010. The operating profit of the company was $1,109.2 million during FY2011, an increase of 39.7% over FY2010. The net profit was $865 million in FY2011, an increase of 47.1% over FY2010.
Reasons to Purchase:
Gain understanding of Shire plc and the factors that influence its strategies
Track strategic initiatives of the company and latest corporate news and actions
Assess Shire plc as a prospective partner, vendor or supplier
Support sales activities by understanding your customers' businesses better
Stay up to date on Shire plc’s business structure, strategy and prospects